Involvement of astrocytes in purine-mediated reparative processes in the brain

International Journal of Developmental Neuroscience

Volumn 19, Issue 4, 2001, Pages 395-414

  Ciccarelli, R ^a   Ballerini, P ^a   Sabatino, G ^b   Rathbone, M P ^c   D'Onofrio, M ^d   Caciagli, F ^a   Di Iorio, P ^a  

^a Section of Pharmacology   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c MCMASTER UNIVERSITY   (Canada)

^d IRCCS NEUROMED   (Italy)

Author keywords

Astrocytes; Brain repair; Neuroprotection; Purines

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE TRIPHOSPHATE; GUANOSINE; GUANOSINE TRIPHOSPHATE; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; PROTEIN S 100; PROTEIN S 100 BETA; PURINE; PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ASTROCYTE; ASTROCYTOSIS; BINDING SITE; BRAIN INJURY; CALCIUM CELL LEVEL; CELL ACTIVITY; CELL DAMAGE; CELL METABOLISM; CELL PROLIFERATION; ENZYME METABOLISM; ISOPRENYLATION; NERVE INJURY; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ADENINE; ADENOSINE TRIPHOSPHATE; ANIMALS; ASTROCYTES; BRAIN; BRAIN DISEASES; BRAIN INJURIES; CELL DIVISION; CHICKENS; ENERGY METABOLISM; EXTRACELLULAR SPACE; GUANINE; GUANOSINE TRIPHOSPHATE; HUMANS; ION TRANSPORT; MICE; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; NUCLEOSIDES; NUCLEOTIDES; RATS; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034987784     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(00)00084-8     Document Type: Review

References (221)

1. Purinergic signalling: Pathophysiological roles
2. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases
3. Adenosine receptors linked to adenylate cyclase activity in human neuroblastoma cells: Modulation during cell differentiation
4. Modulation of astroglial cell proliferation by analogues of adenosine and ATP in primary cultures of rat striatum
5. G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain
6. A novel action for adenosine: Apoptosis of astroglial cells in rat brain primary cultures
7. Adenosine A3 receptors and viability in astrocytes
8. The role of N-6-isopentenyl adenine in tumor cell growth
9. Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion
10. Regulation of ion channels by ABC transporters that secrete ATP
11. 7 like channels in cultured mouse astrocytes
12. 2+ channel modulators on [3H]purine release from rat cultured glial cells
13. 7) receptors regulate intracellular calcium and purine release
14. Ionic modulation of P2X7 receptor-mediated activity in rat brain astrocytes
15. P2X7 ATP receptor-mediated modulation of astrocyte proliferation and coupling
16. Similarities of adenosine uptake systems in astrocytes and neurons in primary cultures
17. Ionic dependence of adenosine uptake into cultured astrocytes
18. Inosine stimulates extensive axon collateral growth in the rat corticospinal tract after injury
19. Transfer RNA modification
20. A novel gliotic P2 receptor mediating cyclooxygenase-2 induction in rat and human astrocytes
21. Fate of cyclic nucleotides in PC12 cell cultures: Uptake, metabolism and effects of metabolites on nerve growth factor-induced neurite outgrowth
22. Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat
23. Developmental changes in the activity of enzymes of purine metabolism in rat neuronal cells in culture and in whole brain
24. Role of adenosine as a modulator of synaptic activity in the central nervous system
25. Purinergic P2Y receptors on astrocytes are directly are directly coupled to phospholipase A2
26. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-β
27. Distribution and role of purinoceptor subtypes
28. Cultures of glial cells release purines under field electrical stimulation: The possible ionic mechanisms
29. Influence of PLA2-PG system on purine release and cAMP content in dissociated primary glial cultures from rat striatum
30. The hypoxanthine analogue AIT-082 mimics the activity of guanosine in affecting extracellular adenosine breakdown and glutamate reuptake in rat cultured astrocytes
31. mGluRs and purinoceptors cooperate in regulating excitatory amino acid and purine release
32. Possible metabolic basis for the different immunodeficient states associated with genetic deficiency of adenosine deaminase and purine nucleoside phosphorylase
33. Differential distribution of purine metabolizing enzymes between glia and neurons
34. A model for adenosine transport and metabolism
35. 2+ responses evoked by ATP and other nucleotides in mammalian brain astrocytes
36. Different pathways of apoptosis revealed by 2-chloroadenosine and deoxy-d-ribose in mammalian astroglial cells
37. Apoptosis induced by 2-chloro-adenosine and 2-choro-2′-deoxy-edenosine in a human astrocytoma cell line: Differential mechanisms and possible clinical relevance
38. Adenosine- and 2-chloro-adenosine-induced cytopathic effects on myoblastic cells and myotubes: Involvement of different intracellular mechanisms
39. Adenosine and guanosine increase free cytosolic calcium concentration in mouse brain astrocytes through different receptors
40. Effects of exogenous ATP and related analogues on the proliferation rate of dissociated primary cultures of rat astrocytes
41. Non-uniform effects mediated by P2Y receptors on the proliferation of cultured astrocytes
42. Isopentenyladenosine involvement in P2-mediated proliferation of cultured rat astrocytes
43. Modulation by metabotropic glutamate receptors of GTP effect on rat astrocyte proliferation
44. Potential neuroprotective effects of guanine-based purines released from rat cultured astrocytes
45. Guanine-based purines are released from rat astrocytes. Effects of these compounds on astrocyte function
46. Activation of A1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S100-β protein from cultured astrocytes
47. Guanosine and related drugs stimulate the production of trophic factors from rat cultured astrocytes by involving mitogen-activated protein kinase pathway
48. Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia
49. A1 adenosine receptors and mGlu3 metabotropic receptors modulate purine release and neurotrophin production from rat cultured astrocytes by different molecular pathways
50. Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia
51. Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors
52. A one-hit model of cell death in inherited neuronal degenerations
53. Adenosine receptor subtypes
54. Purine and pyrimidine nucleotide metabolism
55. Astrocytic gap junctions remain open during ischemic conditions
56. N-Methyl-d-aspartate- and non-N-methyl-d-aspartate-evoked adenosine release from rat cortical slices: Distinct purinergic sources and mechanisms of release
57. Effect of AIT-082 on neurotrophin levels following spinal cord hemisection
58. Extracellular metabolism of adenine nucleotides and adenosine in the innervated skeletal muscle of the frog
59. The mitogen-activated protein kinase signal transduction pathway
60. Absence of guanine deaminase from cerebellum
61. The involvement of ecto-ATPase activity in the phosphorylation of intracellular proteins by the addition of extracellular [32P]ATP in PC12 cells
62. Interaction between A1 adenosine and class II metabotropic glutamate receptors in the regulation of purine and glutamate release from rat hippocampal slices
63. Purinoceptor-mediated modulation of purine and neurotransmitter release from nervous tissue
64. The hypoxanthine derivative AIT-082 is protective against NMDA- or kainic acid-induced rat hippocampal neurotoxicity in vivo
65. Functional role of S100 proteins, calcium-binding proteins of the EF-hand type
66. Requirement for mevalonate in cycling cells: Quantitative and temporal aspects
67. Molecular profile of reactive astrocyte-Implications for their role in neurologic disease
68. Identification, development and regional distribution of ribonucleotide reductase in adult rat brain
69. Purine nucleoside phosphorylase. 1. Structure-function studies
70. Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency
71. Evidence for isopentenyladenine modification on a cell cycle-regulated protein
72. Transforming growth factor-βs in neurodegenerative disease
73. The role of adenosine and 2′-deoxyadenosine in mammalian cells
74. Heterogeneous localization of some purine enzymes in subcellular fractions of rat brain and cerebellum
75. Cell surface adenosine deaminase: Much more than an ectoenzyme
76. Ecto-adenosine deaminase: An ecto-enzyme and a costimulatory protein acting on a variety of cell surface receptors
77. P2 receptor-mediated proliferative effects on astrocyte in vivo
78. Release of 3H-nucleosides from 3H labelled hypothalamic synaptosomes
79. Isopentenyl-adenosine stimulates and inhibits mitosis of human Iymphocytes treated with phytoemoagglutinin
80. Adenosine transport in the CNS
81. Adenosine deaminase and [3H]-nitrobenzylthioinosine as markers of adenosine metabolism and transport in central purinergic system
82. Effect of AIT-082, a purine analogue, on working memory in normal and aged mice
83. A novel purine derivative AIT-082 increases synthesis of NGF, FGF-2 and NT-3 mRNA in astrocytes
84. Elevation of brain mRNA for neurotrophin by oral AIT-082 in mice
85. The hydrolysis of extracellular adenine nucleotides by cultured endothelial cells from pig aorta
86. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs
87. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes
88. GTP and guanosine synergistically enhance NGF-induced neurite outgrowth from PC12 cells
89. Extracellular GTP enhances nerve growth factor-induced neurite outgrowth via increases in intracellular calcium
90. Extracellular adenosine, inosine, hypoxanthine and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia
91. Astroglia and glutamate in physiology and pathology: Aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication
92. Blockade by glibenclamide of the flow-evoked endothelial release of ATP that contributes to vasodilation in the pulmonary vascular bed of the rat
93. Astroglia in CNS injury
94. Inosine mediates the protective effect of adenosine in rat cultured astrocytes subjected to combined glucose-oxygen deprivation
95. 5′-Nucleotidase activates and an inhibitory antibody prevents neuritic differentiation of PC12 cells
96. Nitric oxide and carbon monoxide enhance neurite outgrowth from PC12 cells by activating soluble guanylate cyclase. IUPHAR Satellite Meeting: Nitric Oxide in the Nervous System
97. Stimulation of reactive astrogliosis in vivo by extracellular adenosine diphosphate or an adenosine A2 receptor agonist
98. Adenosine inhibits cell division and promotes neurite extension in PC12 cells
99. Metabolic and biosynthetic alteration in cultured astrocytes exposed to hypoxia/reoxygenation
100. Isopentenyladenine is a mediator of mevalonate-regulated DNA replication
101. 3Hl-adenosine binding in relation to adenylate cyclase activity
102. Adenosine-induced cell death: Evidence for receptor-mediated signalling
103. Production of adenosine from extracellular ATP at the striatal cholinergic synapse
104. Adenosine transport: Recent advances in the molecular biology of nucleoside transporter proteins
105. Noise-induced spiral waves in astrocyte syncytia show evidence of self-organized criticality
106. The hypoxanthine derivative AIT-082 promotes neurite formation and regeneration in cultured hippocampal neurons
107. Adenosine A2A receptors modify motor function in MPTP-treated common marmosets
108. Ecto-adenosine triphosphatase activity at the cholinergic nerve endings of the Torpedo electric organ
109. Purinergic stimulation of astroblast proliferation: Guanosine and its nucleotides stimulate cell division in chick astroblasts
110. Clinical trials in dementia with propentofylline
111. Clinical trials of propentofylline in vascular dementia
112. Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport
113. Quantitative analysis of similarities and differences in neurotoxicities caused by adenosine and 2-deoxyadenosine in sympathetic neurons
114. Effect of a memory-enhancing drug, AIT-082, on the level of synaptophysin
115. Metabolism of extracellular adenine nucleotides by cultured rat brain astrocytes
116. Isoprenoids and astroglial cell cycling: Diminished mevalonate availability and inhibition of dolichol-linked glycoprotein synthesis arrest cycling through distinct mechanisms
117. Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation and energy depletion
118. Deoxyadenosine metabolism and toxicity in cultured L5178Y cells
119. NGF gene expression in actively growing brain glia
120. Potential role of adenosine antagonist therapy in pathological tremor disorders
121. Posttranslational modification of proteins by isoprenoids in mammalian cells
122. Brain guanine deaminase: Purification, properties and regional distribution
123. Cross talk signals in the CNS: Role for neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone-releasing hormone (LHRH)-astroglial interactive network
124. Purine nucleoside phosphorylase deficiency
125. Adenosine metabolism in neurons and astrocytes in primary cultures
126. Effects of adenosine deaminase inhibition on active uptake and metabolism of adenosine in astrocytes in primary cultures
127. Neurotrophins and synaptic plasticity
128. Adenosine formation and release by embryonic chick neurons and glia in cell culture
129. Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes
130. AIT-082, a unique purine derivative, enhances nerve growth factor mediated neurite outgrowth from PC12 cells
131. Extracellular guanosine and guanosine-5′-triphosphate increase NGF synthesis and release from cultured mouse neopallial astrocytes
132. Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: Overview of phase I and phase II clinical trials
133. Role of guanine nucleotides as endogenous ligands of a kainic acid binding site population in the mammalian cerebellum
134. Guanine deaminase from rat brain. Purification, characteristics and contribution to ammoniogenesis in the brain
135. Astrocytes: Form, functions and role in disease
136. Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases
137. Adenosine receptors and their modulators
138. Functional receptors for neurotransmitters on astroglial cells
139. Oral administration of NGF synthesis stimulators recovers reduced brain NGF content in aged rats and cognitive dysfunction in basal-forebrain-lesioned rats
140. Adenosine triphosphate activity at the external surface of chicken brain synaptosomes
141. Ecto-ATPase of mammalian synaptosomes: Identification and enzymatic characterization
142. Signaling by extracellular ATP: Physiological and pathological considerations in neuronal-astrocytic interactions
143. Signaling by ATP receptors in astrocytes
144. ATP stimulates calcium influx in primary astrocyte cultures
145. ATP-evoked calcium signal stimulates protein phosphorylation/ dephospohrylation in astrocytes
146. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells
147. Quantitative aspects of reactive gliosis: A review
148. 2+ mobilization in conjunction with metabotropic glutamate receptor activation by t-ACPD in cultured hippocampal astrocytes
149. 2+-related Al/A2 adenosine receptor cooperation
150. A radical hypothesis for neurodegeneration
151. Cardiovascular purinoceptors
152. Identification of an extracellular motif involved in the binding of guanine nucleotides by a glutamate receptor
153. Differential interaction with and regulation of multiple G proteins by the rat A3 adenosine receptor
154. Effects of propentofylline on adenosine A1 and A2 receptors and nitrobenzylthioinosine-sensitive nucleoside transporters: A quantitative autoradiographical analysis
155. 2+ mobilization and prostanoid release from astrocytes: P2-purinergic receptors linked to phosphoinositide hydrolysis
156. Abnormal purine and pyrimidine nucleotide content in primary astroglia cultures from hypoxanthine-guanine phosphoribosyltransferase-deficient transgenic mice
157. Linkage of the isoprenoid biosynthetic pathway with the induction of DNA synthesis in mouse Iymphocytes. Effect of compactin on mitogen-induced Iymphocytes in serum-free medium
158. New assignment of the adenosine deaminase gene locus to chromosone 20q13 X 11 by study of a patient with interstitial deletion 20q
159. Metabolism of extracellular nucleotides in human airways by a multi-enzyme system
160. 2+-dependent release evoked by 4-aminopyrimidine and veratridine
161. Dissection of astrocyte-mediated cues in neuronal guidance and process extension
162. A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors
163. The effects of AIT-082 on septodentate sprouting after unilateral enthorinal cortex lesions in rats
164. Hippocampal neurons in vitro respond to extracellular guanosine and GTP with neurite outgrowth and branching
165. Purinergic stimulation of cell division and differentiation: Mechanisms and pharmacological implications
166. Purine necleosides and nucleotides stimulate proliferation of a wide range of cell types
167. Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells
168. Effects of guanosine and 2-chloroadenosine on C6 glioma cell growth
169. The trophic effect of purines and purinergic signaling in pathologic reactions of astrocytes
170. Physiology and pharmacology of natural and synthetic nonadenine-based purines in the nervous system
171. Trophic effects of purines in neurons and glial cells
172. Purine-induced apoptosis of astrocytes is mediated by adenosine
173. Allosteric regulation of purine nucleoside phosphorylase
174. + concentration in astrocytes
175. Propentofylline in the treatment of Alzheimer's disease and vascular dementia: A review of phase III trials
176. Adenosine and brain ischemia
177. Manipulation of purinergic tone as a mechanism for controlling ischemic brain damage
178. Adenosine A(1) receptor in cultured neurons from rat cerebral cortex: Colocalization with adenosine deaminase
179. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis
180. Guanosine and GMP prevent seizures induced by quinolinic acid in mice
181. Purine nucleoside cycle: Evidence for the occurrence of the cycle in brain
182. The purine nucleotide cycle: Studies of ammonia production and interconversions of adenine and hypoxanthine nucleotides and nucleosides by rat brain
183. Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells
184. The detection of nucleotides of 5-amino-4-imidazole carboxamide in red cells of patients with the Lesch-Nyhan syndrome
185. Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency
186. Neurotrophic molecules: Strategies for designing effective therapeutic molecules in neurodegeneration
187. Cytokinins
188. Cholesterol and mevalonic acid modulation in cell metabolism and multiplication
189. Analysis of purine nucleoside phosphorylase from human T and non-T lymphocytes of different maturation stages
190. ATP acts as fast neurotransmitter in rat habenula: Neurochemical and enzymecytochemical evidence
191. What do ectoenzymes do?
192. ATP4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes
193. Receptors for adenosine and adenine nucleotides
194. Toxicological and antiproliferative effects of N6- (Δ2-Isopentenyl)adenosine, a natural component of mammalian tRNA
195. The cytolitic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)
196. Stroke in purine nucleoside phosphorylase deficiency
197. Guanine nucleotides inhibit the stimulation of GFAP phosphorylation by glutamate
198. Guanine nucleotides inhibit cAMP accumulation induced by metabotropic glutamate receptor activation
199. ATP release, adenosine formation and modulation of dynorphin and glutamic acid release by adenosine analogues in rat hippocampal mossy fiber synaptosomes
200. Adenosine transport by cultured glial cells from chick embryo brain
201. On the sidedness of plasma membrane enzymes
202. Evidence for a guanosine receptor functionally linked to mitogen-activated protein kinase pathway
203. Neurochemical analysis of focal ischemia in rats
204. Distribution patterns of vimentin-immunoreactive structures in the human prosencephalon during second half of gestation
205. Volume-regulated chloride channels associated with the human multidrug-resistence P-glycoprotein
206. Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion and ischemia
207. Purine nucleoside phosphorylase: A histochemical marker for glial cells
208. Glia-neuron intercommunications and synaptic plasticity
209. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes
210. Exogenous GTP enhances sodium nitrite induced cyclic GMP accumulation in spontaneously beating rat atria
211. Endothelium-dependent and -independent effects of exogenous ATP, adenosine, GTP and guanosine on vascular tone and cyclic nucleotide accumulation of rat mesenteric artery
212. Chemical and physical characterization of cholinergic synaptic vescicles
213. Adenosine protects chick embryonic sympathetic neurons from apoptotic death by 2′-deoxyadenosine - Importance of ATP in apoptosis
214. Defects of tetrahydropterin synthesis and their possible relationship to a disorder of purine metabolism (the Lesch-Nyhan syndrome)
215. Clinical trial designs for demonstrating disease-course-altering effects in dementia
216. Purine ribonucleotide biosynthesis, interconversion and catabolism in mouse brain in vitro
217. Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre
218. Extracellular metabolism of nucleotides in the nervous tissue
219. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system
220. Two novel families of ectonucleotidase: Molecular structures, catalytic properties and a search for function
221. Developmental changes in purine nucleotide metabolism in cultured rat astroglia